Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure
- PMID: 39908111
- PMCID: PMC12059111
- DOI: 10.1681/ASN.0000000654
Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure
Keywords: anemia; chronic hemodialysis; chronic inflammation; hemodialysis.
Conflict of interest statement
Disclosure forms, as provided by each author, are available with the online version of the article at
References
-
- Pergola PE Devalaraja M Fishbane S, et al. . Ziltivekimab for treatment of anemia of inflammation in patients on hemodialysis: results from a phase 1/2 multicenter, randomized, double-blind, placebo-controlled trial. J Am Soc Nephrol. 2021;32(1):211–222. doi:10.1681/ASN.2020050595 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources